Latin American Cannabis News
Appointment expands business and political network and furthers development of medical cannabis education and research across Latin America TORONTO, July 17, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron”...
Aphria plans for global cannabis leadership with international expansion acquiring leading assets in Latin America and the Caribbean Aphria medical brands to gain exposure to over 300 million people,...
Scythian Biosciences Corp Announces Colcanna SAS as one of the Industry’s First to Receive Key Cannabis Licences for the Cultivation, Extraction, Production and Research of Medical Cannabis for the...
TORONTO, July 5, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced...
Canopy Growth introduces Latin American subsidiary Canopy LATAM and announces the acquisition of leading Colombian medical cannabis company Announcement pairs Canopy Growth’s industry leading experience with regional expertise and...
TORONTO, June 26, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced...
Medical Cannabis, Pain and Palliative Care Physician/Researcher will oversee Khiron’s product development and physician’s educational program TORONTO, June 25, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the...
President-Elect’s platform promises significant economic measures to increase foreign investment and international trade TORONTO, June 21, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN),...
Former DEA Chief of Pharmaceutical Investigations leading Khiron’s best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ – Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian integrated medical...
Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients Demonstrates scalability and recurring revenue potential in the Colombian and Latin American markets TORONTO, June...
Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia Colombian Agricultural Institute (“ICA”) authorization is a significant requirement to...
The Colombian Association of Internal Medicine and the Colombian Association of Neurology agree to support Khiron’s development of medical cannabis education, research and professional programs for nearly 3,000 doctors...
Under Mr. Murphy’s guidance, Khiron becomes only medical cannabis producer in Colombiawith DEA-level security protocols TORONTO, May 31, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN), a Canadian...
Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export First Fully Licensed Company in Colombia to Receive INVIMA Approval TORONTO, May 30, 2018 /CNW/ – Khiron life Sciences...
TORONTO, May 29, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the Company is...
Khiron to Commence Trading on TSX Venture Exchange — First Canadian Cannabis Company with Core Operations in Colombia to List on Any Exchange Globally — — Khiron to Host...
Foreign Direct Investment In Cannabis Projects In Colombia. Is The Investment Safe There? Guest post by José Alejandro Abusaid, Founding Partner at Abusaid Gómez 1. Relevance of the...
PharmaCielo and AAJ Announce Private Placement of Subscription Receipts of PharmaCielo for Proceeds of up to $60 Million All financial figures in Canadian Dollars ($) unless otherwise noted TORONTO, April...
PharmaCielo Ltd. to Acquire Colombia’s Leading Provider of Telemedicine Services TORONTO, April 20, 2018 – PharmaCielo Ltd. (the “Company”) announces that it has reached an agreement to acquire Colombia’s...
